RNA Regulation in Neurologic Disease and Cancer

다국어 초록 (Multilingual Abstract)

The paraneoplastic neurologic diseases (PNDs) are brain degenerations that develop in the setting of clinically inapparent cancers. PNDs arise when common cancers express brain proteins, triggering an anti-tumor immune response and tumor immunity. Research on these brain-cancer proteins has revealed a new world of neuron-specific RNA binding proteins whose functions may be aberrantly used by tumor cells. Efforts to gain insight into their function has led to the development of new methods and strategies to understand RNA protein regulation in living tissues.

참고문헌 (Reference)

1 König J, "iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution" 17 : 909-915, 2010

2 Albert ML, "Tumorspecific killer cells in paraneoplastic cerebellar degeneration" 4 : 1321-1324, 1998

3 Hafner M, "Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP" 141 : 129-141, 2010

4 Jensen KB, "The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain" 94 : 5740-5745, 2000

5 Dredge BK, "The splice of life: alternative splicing and neurological disease" 2 : 43-50, 2001

6 Buckanovich RJ, "The onconeural antigen Nova-1 is a neuronspecific RNA-binding protein, the activity of which is inhibited by paraneoplastic antibodies" 16 : 1114-1122, 1996

7 Yang YY, "The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia" 95 : 13254-13259, 1998

8 Buckanovich RJ, "The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo" 17 : 3194-3201, 1997

9 Licatalosi DD, "Splicing regulation in neurologic disease" 52 : 93-101, 2006

10 Sanford JR, "Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts" 19 : 381-394, 2009

11 Lewis HA, "Sequencespecific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome" 100 : 323-332, 2000

12 Licatalosi DD, "RNA processing and its regulation: global insights into biological networks" 11 : 75-87, 2010

13 Darnell RB, "Paraneoplastic syndromes affecting the nervous system" 33 : 270-298, 2006

14 Albert ML, "Paraneoplastic neurological degenerations: keys to tumour immunity" 4 : 36-44, 2004

15 Musunuru K, "Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration" 24 : 239-262, 2001

16 Darnell RB, "Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain" 93 : 4529-4536, 1996

17 Buckanovich RJ, "Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system" 11 : 657-672, 1993

18 Ule J, "Nova regulates brainspecific splicing to shape the synapse" 37 : 844-852, 2005

19 Dredge BK, "Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer" 23 : 4687-4700, 2003

20 Dredge BK, "Nova autoregulation reveals dual functions in neuronal splicing" 24 : 1608-1620, 2005

21 Graus F, "Neuronal antinuclear antibody in sensory neuronopathy from lung cancer" 35 : 538-543, 1985

22 Roberts WK, "Neuroimmunology of the paraneoplastic neurological degenerations" 16 : 616-622, 2004

23 McKeever MO, "NAP, a human cerebellar degeneration antigen, is a novel, neuron specific, adaptin family member [abstract]" 18 : 1092-, 1992

24 Xu M, "MIWI-independent small RNAs (MSY-RNAs) bind to the RNA-binding protein, MSY2, in male germ cells" 106 : 12371-12376, 2009

25 Zhang C, "Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls" 329 : 439-443, 2010

26 Szostak JW, "In vitro selection of functional RNA sequences. In: The RNA world" Cold Spring Harbor Laboratory Press 511-533, 1993

27 Green R, "In vitro genetic analysis: selection and amplification of rare functional nucleic acids" 2 : 75-86, 1991

28 Szabo A, "HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal" 67 : 325-333, 1991

29 Frank MO, "Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer"

30 Darnell RB, "HITS-CLIP: panoramic views of protein-RNA regulation in living cells" 1 : 266-286, 2010

31 Licatalosi DD, "HITS-CLIP yields genome-wide insights into brain alternative RNA processing" 456 : 464-469, 2008

32 Xue Y, "Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping" 36 : 996-1006, 2009

33 Hinman MN, "Diverse molecular functions of Hu proteins" 65 : 3168-3181, 2008

34 Darnell RB, "Developing global insight into RNA regulation" 71 : 321-327, 2006

35 Albert ML, "Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration" 47 : 9-17, 2000

36 Zisoulis DG, "Comprehensive discovery of endogenous Argonaute binding sites in Caenorhabditis elegans" 17 : 173-179, 2010

37 Darnell RB, "Characterization of antigens bound by CSF and serum of a patient with cerebellar degeneration: coexpression in Purkinje cells and tumor lines of neuroectodermal origin" 39 : 385-, 1989

38 Ule J, "CLIP identifies Novaregulated RNA networks in the brain" 302 : 1212-1215, 2003

39 Newman LS, "Beta-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein" 82 : 773-783, 1995

40 Chi SW, "Argonaute HITS-CLIP decodes microRNAmRNA interaction maps" 460 : 479-486, 2009

41 Darnell RB, "Antiserum from a patient with cerebellar degeneration identifies a novel protein in Purkinje cells, cortical neurons, and neuroectodermal tumors" 11 : 1224-1130, 1991

42 Ule J, "An RNA map predicting Nova-dependent splicing regulation" 444 : 580-586, 2006

43 Yeo GW, "An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells" 16 : 130-137, 2009

44 Santomasso BD, "A T-cell receptor associated with naturally occurring human tumor immunity" 104 : 19073-19078, 2007